Chemicals - Specialty
Compare Stocks
2 / 10Stock Comparison
CBT vs ASIX
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals
CBT vs ASIX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Chemicals - Specialty | Chemicals |
| Market Cap | $4.24B | $796M |
| Revenue (TTM) | $3.58B | $1.52B |
| Net Income (TTM) | $285M | $49M |
| Gross Margin | 24.8% | 10.8% |
| Operating Margin | 15.7% | 4.2% |
| Forward P/E | 13.0x | 15.7x |
| Total Debt | $1.22B | $381M |
| Cash & Equiv. | $258M | $20M |
CBT vs ASIX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Cabot Corporation (CBT) | 100 | 227.5 | +127.5% |
| AdvanSix Inc. (ASIX) | 100 | 202.8 | +102.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CBT vs ASIX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CBT carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 4 yrs, beta 0.78, yield 2.2%
- 115.7% 10Y total return vs ASIX's 60.6%
- Lower volatility, beta 0.78, Low D/E 71.3%, current ratio 1.61x
ASIX is the clearest fit if your priority is growth exposure.
- Rev growth 0.3%, EPS growth 11.1%, 3Y rev CAGR -7.9%
- 0.3% revenue growth vs CBT's -7.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 0.3% revenue growth vs CBT's -7.0% | |
| Value | Lower P/E (13.0x vs 15.7x) | |
| Quality / Margins | 8.0% margin vs ASIX's 3.2% | |
| Stability / Safety | Beta 0.78 vs ASIX's 0.81 | |
| Dividends | 2.2% yield, 4-year raise streak, vs ASIX's 2.6% | |
| Momentum (1Y) | +13.8% vs ASIX's +8.2% | |
| Efficiency (ROA) | 7.4% ROA vs ASIX's 2.9%, ROIC 17.4% vs 4.4% |
CBT vs ASIX — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CBT vs ASIX — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
CBT leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CBT is the larger business by revenue, generating $3.6B annually — 2.3x ASIX's $1.5B. Profitability is closely matched — net margins range from 8.0% (CBT) to 3.2% (ASIX). On growth, ASIX holds the edge at +9.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $3.6B | $1.5B |
| EBITDAEarnings before interest/tax | $731M | $143M |
| Net IncomeAfter-tax profit | $285M | $49M |
| Free Cash FlowCash after capex | $459M | $6M |
| Gross MarginGross profit ÷ Revenue | +24.8% | +10.8% |
| Operating MarginEBIT ÷ Revenue | +15.7% | +4.2% |
| Net MarginNet income ÷ Revenue | +8.0% | +3.2% |
| FCF MarginFCF ÷ Revenue | +12.8% | +0.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | -3.4% | +9.4% |
| EPS Growth (YoY)Latest quarter vs prior year | -23.1% | -8.8% |
Valuation Metrics
Evenly matched — CBT and ASIX each lead in 3 of 6 comparable metrics.
Valuation Metrics
At 13.3x trailing earnings, ASIX trades at a 1% valuation discount to CBT's 13.5x P/E. On an enterprise value basis, CBT's 6.7x EV/EBITDA is more attractive than ASIX's 7.9x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $4.2B | $796M |
| Enterprise ValueMkt cap + debt − cash | $5.2B | $1.2B |
| Trailing P/EPrice ÷ TTM EPS | 13.50x | 13.34x |
| Forward P/EPrice ÷ next-FY EPS est. | 13.04x | 15.74x |
| PEG RatioP/E ÷ EPS growth rate | — | 7.10x |
| EV / EBITDAEnterprise value multiple | 6.71x | 7.86x |
| Price / SalesMarket cap ÷ Revenue | 1.14x | 0.52x |
| Price / BookPrice ÷ Book value/share | 2.58x | 0.80x |
| Price / FCFMarket cap ÷ FCF | 10.86x | 124.10x |
Profitability & Efficiency
CBT leads this category, winning 5 of 8 comparable metrics.
Profitability & Efficiency
CBT delivers a 16.8% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $6 for ASIX. ASIX carries lower financial leverage with a 0.47x debt-to-equity ratio, signaling a more conservative balance sheet compared to CBT's 0.71x.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +16.8% | +6.0% |
| ROA (TTM)Return on assets | +7.4% | +2.9% |
| ROICReturn on invested capital | +17.4% | +4.4% |
| ROCEReturn on capital employed | +21.3% | +5.3% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 6 |
| Debt / EquityFinancial leverage | 0.71x | 0.47x |
| Net DebtTotal debt minus cash | $957M | $361M |
| Cash & Equiv.Liquid assets | $258M | $20M |
| Total DebtShort + long-term debt | $1.2B | $381M |
| Interest CoverageEBIT ÷ Interest expense | 14.72x | 7.92x |
Total Returns (Dividends Reinvested)
CBT leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CBT five years ago would be worth $14,321 today (with dividends reinvested), compared to $8,411 for ASIX. Over the past 12 months, CBT leads with a +13.8% total return vs ASIX's +8.2%. The 3-year compound annual growth rate (CAGR) favors CBT at 7.0% vs ASIX's -9.4% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +21.9% | +40.3% |
| 1-Year ReturnPast 12 months | +13.8% | +8.2% |
| 3-Year ReturnCumulative with dividends | +22.5% | -25.6% |
| 5-Year ReturnCumulative with dividends | +43.2% | -15.9% |
| 10-Year ReturnCumulative with dividends | +115.7% | +60.6% |
| CAGR (3Y)Annualised 3-year return | +7.0% | -9.4% |
Risk & Volatility
CBT leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CBT is the less volatile stock with a 0.78 beta — it tends to amplify market swings less than ASIX's 0.81 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CBT currently trades 96.1% from its 52-week high vs ASIX's 89.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.78x | 0.81x |
| 52-Week HighHighest price in past year | $84.60 | $26.73 |
| 52-Week LowLowest price in past year | $58.33 | $14.10 |
| % of 52W HighCurrent price vs 52-week peak | +96.1% | +89.8% |
| RSI (14)Momentum oscillator 0–100 | 71.7 | 60.6 |
| Avg Volume (50D)Average daily shares traded | 374K | 453K |
Analyst Outlook
Evenly matched — CBT and ASIX each lead in 1 of 2 comparable metrics.
Analyst Outlook
Wall Street rates CBT as "Buy" and ASIX as "Buy". Consensus price targets imply -4.0% upside for CBT (target: $78) vs -8.4% for ASIX (target: $22). For income investors, ASIX offers the higher dividend yield at 2.62% vs CBT's 2.18%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $78.00 | $22.00 |
| # AnalystsCovering analysts | 15 | 6 |
| Dividend YieldAnnual dividend ÷ price | +2.2% | +2.6% |
| Dividend StreakConsecutive years of raises | 4 | 0 |
| Dividend / ShareAnnual DPS | $1.77 | $0.63 |
| Buyback YieldShare repurchases ÷ mkt cap | +4.0% | +0.2% |
CBT leads in 4 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 2 categories are tied.
CBT vs ASIX: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is CBT or ASIX a better buy right now?
For growth investors, AdvanSix Inc.
(ASIX) is the stronger pick with 0. 3% revenue growth year-over-year, versus -7. 0% for Cabot Corporation (CBT). AdvanSix Inc. (ASIX) offers the better valuation at 13. 3x trailing P/E (15. 7x forward), making it the more compelling value choice. Analysts rate Cabot Corporation (CBT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CBT or ASIX?
On trailing P/E, AdvanSix Inc.
(ASIX) is the cheapest at 13. 3x versus Cabot Corporation at 13. 5x. On forward P/E, Cabot Corporation is actually cheaper at 13. 0x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — CBT or ASIX?
Over the past 5 years, Cabot Corporation (CBT) delivered a total return of +43.
2%, compared to -15. 9% for AdvanSix Inc. (ASIX). Over 10 years, the gap is even starker: CBT returned +115. 7% versus ASIX's +60. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CBT or ASIX?
By beta (market sensitivity over 5 years), Cabot Corporation (CBT) is the lower-risk stock at 0.
78β versus AdvanSix Inc. 's 0. 81β — meaning ASIX is approximately 3% more volatile than CBT relative to the S&P 500. On balance sheet safety, AdvanSix Inc. (ASIX) carries a lower debt/equity ratio of 47% versus 71% for Cabot Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — CBT or ASIX?
By revenue growth (latest reported year), AdvanSix Inc.
(ASIX) is pulling ahead at 0. 3% versus -7. 0% for Cabot Corporation (CBT). On earnings-per-share growth, the picture is similar: AdvanSix Inc. grew EPS 11. 1% year-over-year, compared to -10. 4% for Cabot Corporation. Over a 3-year CAGR, CBT leads at -4. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CBT or ASIX?
Cabot Corporation (CBT) is the more profitable company, earning 8.
9% net margin versus 3. 2% for AdvanSix Inc. — meaning it keeps 8. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CBT leads at 16. 7% versus 4. 4% for ASIX. At the gross margin level — before operating expenses — CBT leads at 25. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CBT or ASIX more undervalued right now?
On forward earnings alone, Cabot Corporation (CBT) trades at 13.
0x forward P/E versus 15. 7x for AdvanSix Inc. — 2. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CBT: -4. 0% to $78. 00.
08Which pays a better dividend — CBT or ASIX?
All stocks in this comparison pay dividends.
AdvanSix Inc. (ASIX) offers the highest yield at 2. 6%, versus 2. 2% for Cabot Corporation (CBT).
09Is CBT or ASIX better for a retirement portfolio?
For long-horizon retirement investors, Cabot Corporation (CBT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
78), 2. 2% yield, +115. 7% 10Y return). Both have compounded well over 10 years (CBT: +115. 7%, ASIX: +60. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CBT and ASIX?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.